Page last updated: 2024-10-28

haloperidol and Leukemia

haloperidol has been researched along with Leukemia in 3 studies

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research Excerpts

ExcerptRelevanceReference
"Haloperidol was less potent than verapamil."1.31Reversal of vinblastine resistance in human leukemic cells by haloperidol and dihydrohaloperidol. ( Fujita, R; Furusawa, S; Ishikawa, M; Kataoka, Y; Miura, M; Sasaki, K; Takayanagi, M; Takayanagi, Y; Takeshita, M, 2001)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vilner, BJ1
John, CS1
Bowen, WD1
Kataoka, Y1
Ishikawa, M1
Miura, M1
Takeshita, M1
Fujita, R1
Furusawa, S1
Takayanagi, M1
Takayanagi, Y1
Sasaki, K1
Weisenthal, LM1
Su, YZ1
Duarte, TE1
Dill, PL1
Nagourney, RA1

Other Studies

3 other studies available for haloperidol and Leukemia

ArticleYear
Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.
    Cancer research, 1995, Jan-15, Volume: 55, Issue:2

    Topics: Adenocarcinoma; Animals; Binding, Competitive; Breast Neoplasms; Carcinoma, Ductal, Breast; Glioblas

1995
Reversal of vinblastine resistance in human leukemic cells by haloperidol and dihydrohaloperidol.
    Biological & pharmaceutical bulletin, 2001, Volume: 24, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides;

2001
Perturbation of in vitro drug resistance in human lymphatic neoplasms by combinations of putative inhibitors of protein kinase C.
    Cancer treatment reports, 1987, Volume: 71, Issue:12

    Topics: Cell Survival; Chlorpromazine; Drug Resistance; Drug Synergism; Haloperidol; Humans; Imipramine; In

1987